Re: Report Of Exempt Distribution.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2690 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Report Of Exempt Distribution.

in response to

Report Of Exempt Distribution.

KOO-KOO2

posted on Apr 16, 2024 07:13PM

What is this exemption distribution? another of DM loan to RVX , a Peter to pay Paul loan to keep RVX a float . just get a zenith deal done , its getting pathetic already

7 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply